Novonesis B ADR (NVZMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 380,058 | 236,808 | 126,521 | 500,370 | 399,989 |
| Income taxes - deferred | -60,209 | -49,335 | -42,978 | -99,756 | -45,201 |
| Accounts receivable | -23,272 | -17,303 | -41,621 | -91,323 | -69,308 |
| Accounts payable and accrued liabilities | 31,119 | 5,005 | -23,977 | 82,414 | 34,258 |
| Other Working Capital | -83,345 | -71,786 | -74,495 | -97,369 | -105,628 |
| Other Operating Activity | 218,645 | 211,497 | 173,420 | 351,929 | 319,896 |
| Operating Cash Flow | $462,997 | $314,886 | $116,870 | $646,264 | $534,006 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -257,611 | -170,456 | -57,153 | -150,668 | -84,217 |
| Net Acquisitions | 25,707 | -11,011 | -8,294 | -259,492 | -120,695 |
| Purchase Sale Intangibles | -8,118 | -5,863 | -1,508 | -26,888 | -16,970 |
| Other Investing Activity | -8,118 | -5,863 | -1,508 | -26,888 | -16,970 |
| Investing Cash Flow | $-240,022 | $-187,330 | $-66,955 | $-437,048 | $-221,881 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 283,995 | 283,140 | 196,492 | 390,909 | 269,937 |
| Debt Repayment | -184,820 | -120,978 | -18,096 | -204,125 | -189,686 |
| Common Stock Issued | 14,612 | 12,870 | 7,540 | 49,162 | 41,077 |
| Common Stock Repurchased | -67,650 | -71,500 | -21,112 | -238,650 | -237,900 |
| Dividend Paid | -206,333 | -218,075 | -229,819 | -233,241 | -232,508 |
| Other Financing Activity | -12,042 | -8,294 | 36,041 | -16,387 | -12,212 |
| Financing Cash Flow | $-172,237 | $-122,837 | $-28,954 | $-252,333 | $-361,291 |
| Exchange Rate Effect | 5,277 | 2,431 | -754 | 8,432 | -1,269 |
| Beginning Cash Position | 130,294 | 137,709 | 145,220 | 187,897 | 187,307 |
| End Cash Position | 186,308 | 144,859 | 165,428 | 153,213 | 136,872 |
| Net Cash Flow | $56,014 | $7,150 | $20,207 | $-34,684 | $-50,435 |
| Free Cash Flow | |||||
| Operating Cash Flow | 462,997 | 314,886 | 116,870 | 646,264 | 534,006 |
| Capital Expenditure | -261,129 | -170,599 | -57,304 | -170,396 | -84,692 |
| Free Cash Flow | 201,868 | 144,287 | 59,566 | 475,868 | 449,314 |